Page last updated: 2024-11-03

propranolol and Sarcoma

propranolol has been researched along with Sarcoma in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.

Research Excerpts

ExcerptRelevanceReference
"Standard chemotherapy for soft tissue sarcomas has shown limited efficacy."5.56The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study. ( Azzariti, A; Di Fonte, R; Fucci, L; Garofoli, M; Guida, M; Porcelli, L; Strippoli, S; Volpicella, M, 2020)
"Standard chemotherapy for soft tissue sarcomas has shown limited efficacy."1.56The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study. ( Azzariti, A; Di Fonte, R; Fucci, L; Garofoli, M; Guida, M; Porcelli, L; Strippoli, S; Volpicella, M, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Porcelli, L1
Garofoli, M1
Di Fonte, R1
Fucci, L1
Volpicella, M1
Strippoli, S1
Guida, M1
Azzariti, A1
Lee, ATJ1
Huang, PH1
Pollack, SM1
Jones, RL1

Other Studies

2 other studies available for propranolol and Sarcoma

ArticleYear
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.
    Scientific reports, 2020, 06-26, Volume: 10, Issue:1

    Topics: Adrenergic beta-Antagonists; Cell Line, Tumor; Cyclooxygenase 2; Doxorubicin; Drug Resistance, Neopl

2020
Drug repositioning in sarcomas and other rare tumors.
    EBioMedicine, 2016, Volume: 6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Repositioning; Humans; P

2016